Strata Net Income from 2010 to 2026

SRTA Stock   4.47  0.12  2.61%   
Strata Critical's Net Loss is decreasing over the years with slightly volatile fluctuation. Net Loss is expected to dwindle to about -25.8 M. From 2010 to 2026 Strata Critical Net Loss quarterly data regression line had arithmetic mean of (18,800,966) and significance of  0. View All Fundamentals
 
Net Loss  
First Reported
2019-09-30
Previous Quarter
-3.7 M
Current Value
57.4 M
Quarterly Volatility
15.5 M
 
Covid
 
Interest Hikes
Check Strata Critical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Strata Critical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.2 M, Selling General Administrative of 53 M or Selling And Marketing Expenses of 6.7 M, as well as many indicators such as Price To Sales Ratio of 1.45, Dividend Yield of 0.0 or PTB Ratio of 1.62. Strata financial statements analysis is a perfect complement when working with Strata Critical Valuation or Volatility modules.
  
Build AI portfolio with Strata Stock
Check out the analysis of Strata Critical Correlation against competitors.
Analyzing Strata Critical's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing Strata Critical's current valuation and future prospects.

Latest Strata Critical's Net Income Growth Pattern

Below is the plot of the Net Income of Strata Critical Medical over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Strata Critical Medical financial statement analysis. It represents the amount of money remaining after all of Strata Critical Medical operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Strata Critical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Strata Critical's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (27.31 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Strata Net Income Regression Statistics

Arithmetic Mean(18,800,966)
Coefficient Of Variation(70.06)
Mean Deviation10,384,779
Median(10,838,000)
Standard Deviation13,172,200
Sample Variance173.5T
Range45.9M
R-Value(0.65)
Mean Square Error106.6T
R-Squared0.42
Significance0
Slope(1,698,243)
Total Sum of Squares2776.1T

Strata Net Income History

2026-25.8 M
2025-24.6 M
2024-27.3 M
2023-56.1 M
2022-27.3 M
2021-40.1 M
2020-10.2 M

Other Fundumenentals of Strata Critical Medical

Strata Critical Net Income component correlations

About Strata Critical Financial Statements

Strata Critical stakeholders use historical fundamental indicators, such as Strata Critical's Net Income, to determine how well the company is positioned to perform in the future. Although Strata Critical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Strata Critical's assets and liabilities are reflected in the revenues and expenses on Strata Critical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Strata Critical Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-24.6 M-25.8 M
Net Loss-31.4 M-33 M
Net Loss(0.32)(0.33)
Net Income Per E B T 0.89  0.77 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Strata Critical Medical is a strong investment it is important to analyze Strata Critical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Strata Critical's future performance. For an informed investment choice regarding Strata Stock, refer to the following important reports:
Check out the analysis of Strata Critical Correlation against competitors.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Ground Transportation space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Strata Critical. If investors know Strata will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Strata Critical assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.24)
Revenue Per Share
1.244
Quarterly Revenue Growth
2.083
Return On Assets
(0.11)
Return On Equity
(0.24)
The market value of Strata Critical Medical is measured differently than its book value, which is the value of Strata that is recorded on the company's balance sheet. Investors also form their own opinion of Strata Critical's value that differs from its market value or its book value, called intrinsic value, which is Strata Critical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Strata Critical's market value can be influenced by many factors that don't directly affect Strata Critical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Strata Critical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Strata Critical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Strata Critical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.